Rigel Announces Fourth Quarter 2016 and Year End 2016 Financial Results and Provides Company Update

Go back to Rigel Announces Fourth Quarter 2016 and Year End 2016 Financial Results and Provides Company Update

Rigel Pharma (RIGL) Tops Q4 EPS by 1c

March 7, 2017 4:06 PM EST

Rigel Pharma (NASDAQ: RIGL) reported Q4 EPS of ($0.16), $0.01 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $3 million versus the consensus estimate of $4.25 million.

For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.

... More